Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.
about
Vascular Remodelling and Mesenchymal Transition in Systemic SclerosisCirculating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary HypertensionThe quest for biomarker discovery in pulmonary arterial hypertension: the right takes lessons from the leftUpdate in Pulmonary Vascular Disease 2015.Exhaled nitric oxide in pulmonary arterial hypertension associated with systemic sclerosisRecent advances in managing systemic sclerosis.Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension.Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.Ambrisentan: a review of its use in pulmonary arterial hypertension.Epidemiology and treatment of pulmonary arterial hypertension.Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.Independence Day: Separating Right Ventricular Function From Pulmonary Arterial Hypertension in Systemic Sclerosis.Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma Pulmonary Arterial Hypertension.The evolving landscape of combination therapy for pulmonary arterial hypertension.Screening and Early Detection of Pulmonary Arterial Hypertension in Connective Tissue Diseases. It Is Time to Institute It!The success of pulmonary hypertension treatment: improved cardiac function by reducing the arterial load.Translational Advances in the Field of Pulmonary Hypertension. Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension.Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.Evaluation and management approaches for scleroderma lung disease.Right Ventricle Remodeling and Function in Scleroderma Patients.Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?
P2860
Q26749091-FF703AF8-EB8E-4925-BAA8-0614CBD82EA3Q28109687-3BDBC282-6C5B-4D7B-A7B0-3B2A6CDA3A3EQ36593457-6089383E-4D13-4D82-81BB-E6A2FB140B2AQ37013164-14E21383-5A37-41BE-B4A8-958B2D6D60E0Q37555421-C564F1AD-0E85-4677-B2DC-727202E4664AQ38759138-934EC373-A077-48B0-B620-F35C27B718FBQ38887196-9C499589-96A8-461D-BEB8-5D71BE93E69CQ38914965-14070983-7C91-4ECA-8CB4-9EC6DAA3231BQ39251587-8D5D2031-36D2-4695-A693-4BD621F19315Q39359218-1CC45C85-C5AA-4FDC-B001-B301B9337AC0Q41146142-C0C3A049-0C4A-4909-BCFC-76BFFD40B6E9Q42475025-454A0044-2D98-4BAB-8EAA-35538AC8218CQ44970403-0E3BB21F-C231-4301-8490-0AAB5288EA0DQ47791625-B19960B9-6874-4CF5-9D96-14E67FBF4A18Q47975605-2017FDE1-6085-4793-9F3A-E531E7CF5FE4Q49716762-389023BC-1DD6-4464-AE32-848A7335537BQ50476552-891EF7BF-ACBC-41E3-A1E6-C93D18B02696Q50672722-C1D1F3AA-9747-4614-B579-AC9E95D6E971Q52939870-619F3A53-DC85-4C18-AED4-F5F40F12912EQ55153213-42935714-BD4D-461E-A8E8-A330C66F1369Q57484162-4B9BF833-8DC6-4201-85C2-AF7774B78E8A
P2860
Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Ambrisentan and Tadalafil Up-f ...... lmonary Arterial Hypertension.
@ast
Ambrisentan and Tadalafil Up-f ...... lmonary Arterial Hypertension.
@en
type
label
Ambrisentan and Tadalafil Up-f ...... lmonary Arterial Hypertension.
@ast
Ambrisentan and Tadalafil Up-f ...... lmonary Arterial Hypertension.
@en
prefLabel
Ambrisentan and Tadalafil Up-f ...... lmonary Arterial Hypertension.
@ast
Ambrisentan and Tadalafil Up-f ...... lmonary Arterial Hypertension.
@en
P2093
P2860
P1476
Ambrisentan and Tadalafil Up-f ...... lmonary Arterial Hypertension.
@en
P2093
Celia P Corona-Villalobos
Chiara Pisanello
Erica H Pullins
Fernando Torres
Kelly Chin
Mohamed A Gashouta
Noah Lechtzin
Olivia L Hulme
Omar A Minai
Paul M Hassoun
P2860
P304
P356
10.1164/RCCM.201507-1398OC
P407
P577
2015-09-11T00:00:00Z